Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R 89439
2. R-89439
1. 147362-57-0
2. R 89439
3. R-89439
4. Chembl37624
5. 3s1r1lz09h
6. 2-((2-acetyl-5-methylphenyl)amino)-2-(2,6-dichlorophenyl)acetamide
7. 141030-40-2
8. 2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide
9. Unii-3s1r1lz09h
10. Loviride [usan:inn:ban]
11. Loveride
12. Alpha-apa
13. .alpha.-apa
14. Starbld0009613
15. Loviride [usan]
16. Loviride (usan/inn)
17. Loviride [inn]
18. Loviride [mart.]
19. Loviride [who-dd]
20. Schembl247781
21. Dtxsid60869958
22. (+-)-2-(6-acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide
23. Bdbm50030539
24. Benzeneacetamide, Alpha-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-
25. Benzeneacetamide, Alpha-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-, (+-)-
26. Hy-15355
27. Cs-0005982
28. D04786
29. R89439
30. Q6692646
31. 2-(2-acetyl-5-methyl-anilino)-2-(2,6-dichlorophenyl)acetamide
32. (+/-)-2,6-dichloro-.alpha.-[(2-acetyl-5-methylphenyl)amino]benzamide
33. (+/-)-2-(6-acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide
34. 2-(2-acetyl-5-methyl-phenylamino)-2-(2,6-dichloro-phenyl)-acetamide
35. Benzeneacetamide, .alpha.-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-, (+/-)-
Molecular Weight | 351.2 g/mol |
---|---|
Molecular Formula | C17H16Cl2N2O2 |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 350.0588831 g/mol |
Monoisotopic Mass | 350.0588831 g/mol |
Topological Polar Surface Area | 72.2 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 436 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?